Systemic Redox Imbalance in Chronic Kidney Disease: A Systematic Review

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Poulianiti, Konstantina P ^a   Kaltsatou, Antonia ^a   Mitrou, Georgia I ^a   Jamurtas, Athanasios Z ^a,b   Koutedakis, Yiannis ^a,b,c   Maridaki, Maria ^d   Stefanidis, Ioannis ^a   Sakkas, Giorgos K ^a,b,e   Karatzaferi, Christina ^a,b,e  

^a UNIVERSITY OF THESSALY   (Greece)

^b Institute for Research and Technology Thessaly   (Greece)

^c UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

^d UNIVERSITY OF ATHENS   (Greece)

^e PLYMOUTH MARJON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; CARBONYLATION; DIALYSIS; OCCUPATIONAL DISEASES;

ANTIOXIDANT DEFENSE; CHRONIC KIDNEY DISEASE; EARLY INTERVENTION; KIDNEY FUNCTION; LIPID PEROXIDATION; PROTEIN CARBONYLATION; REACTIVE SPECIES; SYSTEMATIC REVIEW;

DISEASES;

ANTIOXIDANT; REACTIVE OXYGEN METABOLITE;

ATHEROGENESIS; CHRONIC KIDNEY DISEASE; COCHRANE LIBRARY; DISEASE COURSE; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; LIPID PEROXIDATION; MEDLINE; OXIDATION REDUCTION STATE; PROTEIN CARBONYLATION; REVIEW; SCOPUS; SYSTEMATIC REVIEW (TOPIC); ANIMAL; KIDNEY; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC;

ANIMALS; ANTIOXIDANTS; HUMANS; KIDNEY; LIPID PEROXIDATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROGNOSIS; PROTEIN CARBONYLATION; REACTIVE OXYGEN SPECIES; RENAL INSUFFICIENCY, CHRONIC;

EID: 84984887774     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/8598253     Document Type: Review

References (103)

1. B. Baýes, M. C. Pastor, J. Bonal, A. Foraster, and R. Romero, "Oxidative stress, inflammation and cardiovascularmortality in haemodialysis-role of seniority and intravenous ferrotherapy: Analysis at 4 years of follow-up, " Nephrology Dialysis Transplantation, vol. 21, no. 4, pp. 984-990, 2006.
2. P. Stenvinkel and P. Baŕany, "Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure: links to inflammation and oxidative stress, " Nephrology Dialysis Transplantation, vol. 17, supplement 5, pp. 32-37, 2002.
3. H. Terawaki, K. Yoshimura, T. Hasegawa et al., "Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin, " Kidney International, vol. 66, no. 5, pp. 1988-1993, 2004.
4. I. C. Macdougall and A. Cooper, "The inflammatory response and epoetin sensitivity, " Nephrology Dialysis Transplantation, vol. 17, supplement 1, pp. 48-52, 2002.
5. T. Grune, O. Sommerburg, andW. G. Siems, "Oxidative stress in anemia, " Clinical Nephrology, vol. 53, supplement 1, pp. S18-S22, 2000.
6. E. O. Gosmanova and N.-A. Le, "Cardiovascular complications in CKD patients: role of oxidative stress, " Cardiology Research and Practice, vol. 2011, Article ID 156326, 8 pages, 2011.
7. T. Drüeke, V. Witko-Sarsat, Z. Massy et al., "Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease, " Circulation, vol. 106, no. 17, pp. 2212-2217, 2002.
8. X.-B. Yang, F.-F. Hou, Q. Wu et al., "Increased levels of advanced oxidation protein products are associated with atherosclerosis in chronic kidney disease, " Zhonghua Nei Ke Za Zhi, vol. 44, no. 5, pp. 342-346, 2005.
9. T. Shoji, E. Kimoto, K. Shinohara et al., "The association of antibodies against oxidized low-density lipoprotein with atherosclerosis in hemodialysis patients, " Kidney International Supplements, vol. 63, no. 84, pp. S128-S130, 2003.
10. A. Ayala, M. F. Muñoz, and S. Argüelles, "Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal, " Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 360438, 31 pages, 2014.
11. E. Peuchant, M.-C. Delmas-Beauvieux, L. Dubourg et al., "Antioxidant effects of a supplemented very low protein diet in chronic renal failure, " Free Radical Biology andMedicine, vol. 22, no. 1-2, pp. 313-320, 1996.
12. I. Ceballos-Picot, V. Witko-Sarsat, M. Merad-Boudia et al., "Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure, " Free Radical Biology andMedicine, vol. 21, no. 6, pp. 845-853, 1996.
13. E. A. Ross, L. C. Koo, and J. B. Moberly, "Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients, " American Journal of Kidney Diseases, vol. 30, no. 4, pp. 489-494, 1997.
14. R. K. Sindhu, A. Ehdaie, F. Farmand et al., "Expression of catalase and glutathione peroxidase in renal insufficiency, " Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, vol. 1743, no. 1-2, pp. 86-92, 2005.
15. C. S. Wilcox, "Redox regulation of the afferent arteriole and tubuloglomerular feedback, " Acta Physiologica Scandinavica, vol. 179, no. 3, pp. 217-223, 2003.
16. J. Zimmermann, S. Herrlinger, A. Pruy, T. Metzger, and C. Wanner, "Inflammation enhances cardiovascular risk and mortality in hemodialysis patients, " Kidney International, vol. 55, no. 2, pp. 648-658, 1999.
17. K. Hensley, K.A. Robinson, S. P. Gabbita, S. Salsman, and R.A. Floyd, "Reactive oxygen species, cell signaling, and cell injury, " Free Radical Biology andMedicine, vol. 28, no. 10, pp. 1456-1462, 2000.
18. S.-I. Yamagishi, Y. Inagaki, T. Okamoto et al., "Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells, " The Journal of Biological Chemistry, vol. 277, no. 23, pp. 20309-20315, 2002.
19. M. P. C. Grooteman, J. C. Bos, A. J. Van Houte, J. Van Limbeck, M. Schoorl, and M. J. Nube, "Mechanisms of intra-dialyser granulocyte activation: A sequential dialyser elution study, " Nephrology Dialysis Transplantation, vol. 12, no. 3, pp. 492-499, 1997.
20. M. Morena, J.-P. Cristol, and B. Canaud, "Why hemodialysis patients are in a prooxidant state?What could be done to correct the pro/antioxidant imbalance, " Blood Purification, vol. 18, no. 3, pp. 191-199, 2000.
21. H. Miyazaki, H. Matsuoka, H. Itabe et al., "Hemodialysis impairs endothelial function via oxidative stress: effects of vitamin E-coated dialyzer, " Circulation, vol. 101, no. 9, pp. 1002-1006, 2000.
22. J. Nourooz-Zadeh, "Effect of dialysis on oxidative stress in uraemia, " Redox Report, vol. 4, no. 1-2, pp. 17-22, 1999.
23. B. Canaud, J.-P. Cristol, M. Morena, H. Leray-Moragues, J.-Y. Bosc, and F. Vaussenat, "Imbalance of oxidants and antioxidants in haemodialysis patients, " Blood Purification, vol. 17, no. 2-3, pp. 99-106, 1999.
24. J. P. T. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions, Cochrane Book Series, The Cochrane Collaboration and JohnWiley & Sons Ltd, New York, NY, USA, 2008.
25. D. Moher, A. Liberati, J. Tetzlaff et al., "Preferred reporting items for systematic reviews and meta-Analyses: The PRISMA statement, " Annals of Internal Medicine, vol. 151, no. 4, pp. 264-269, 2009.
26. National Guideline Clearinghouse, "KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease, " March 2016, https://www.guideline .gov/content.aspx?id=46510.
27. N. Sahni, K. L. Gupta, S. V. Rana, R. Prasad, and A. K. Bhalla, "Intake of antioxidants and their status in chronic kidney disease patients, " Journal of Renal Nutrition, vol. 22, no. 4, pp. 389-399, 2012.
28. E. C. Papavasiliou, C. Gouva, K. C. Siamopoulos, and A. D. Tselepis, "Erythrocyte PAF-Acetylhydrolase activity in various stages of chronic kidney disease: effect of long-Term therapy with erythropoietin, " Kidney International, vol. 68, no. 1, pp. 246-255, 2005.
29. J. Bober, K. Kedzierska, E. Kwiatkowska et al., "Does oxidative stress affect the activity of the sodium-proton exchanger?" Annales Academiae Medicae Stetinensis, vol. 56, no. 3, pp. 5-12, 2010.
30. J.-Y. Choi, Y. J. Yoon, H.-J. Choi et al., "Dialysis modalitydependent changes in serum metabolites: Accumulation of inosine and hypoxanthine in patients on haemodialysis, " Nephrology Dialysis Transplantation, vol. 26, no. 4, pp. 1304-1313, 2011.
31. Y. Yawata and H. S. Jacob, "Abnormal red cell metabolism in patients with chronic uremia: nature of the defect and its persistence despite adequate hemodialysis, " Blood, vol. 45, no. 2, pp. 231-239, 1975.
32. R. Schiavon, G. C. Guidi, S. Biasioli, E. De Fanti, and L. Targa, "Plasma glutathione peroxidase activity as an index of renal function, " European Journal of Clinical Chemistry and Clinical Biochemistry, vol. 32, no. 10, pp. 759-765, 1994.
33. A. S. Yalçin, M. Yurtkuran, K. Dilek, A. Kilinç, Y. Taga, and K. Emerk, "The effect of vitamin E therapy on plasma and erythrocyte lipid peroxidation in chronic hemodialysis patients, " Clinica Chimica Acta, vol. 185, no. 1, pp. 109-112, 1989.
34. A. Ganguli, H. S. Kohli, M. Khullar, K. Lal Gupta, V. Jha, and V. Sakhuja, "Lipid peroxidation products formation with various intravenous iron preparations in chronic kidney disease, " Renal Failure, vol. 31, no. 2, pp. 106-110, 2009.
35. J. Marsillach, A. Martinez-Vea, L. Marcas et al., "Administration of exogenous erythropoietin affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia, " Clinical and Experimental Pharmacology and Physiology, vol. 34, no. 4, pp. 347-349, 2007.
36. L. F. Ramos, J. Kane, E. McMonagle et al., "Effects of combination tocopherols and alpha lipoic acid therapy on oxidative stress and inflammatory biomarkers in chronic kidney disease, " Journal of Renal Nutrition, vol. 21, no. 3, pp. 211-218, 2011.
37. J. J. Moreillon, R. G. Bowden, E. Deike et al., "The use of an anti-inflammatory supplement in patients with chronic kidney disease, " Journal of Complementary & Integrative Medicine, vol. 10, 2013.
38. L. J. Roberts II, J. A. Oates, M. F. Linton et al., "The relationship between dose of vitamin E and suppression of oxidative stress in humans, " Free Radical Biology &Medicine, vol. 43, no. 10, pp. 1388-1393, 2007.
39. H. Hatcher, R. Planalp, J. Cho, F. M. Torti, and S. V. Torti, "Curcumin: from ancient medicine to current clinical trials, " Cellular andMolecular Life Sciences, vol. 65, no. 11, pp. 1631-1652, 2008.
40. I. Gupta, A. Parihar, P. Malhotra et al., "Effects of gum resin of Boswellia serrata in patients with chronic colitis, " PlantaMedica, vol. 67, no. 5, pp. 391-395, 2001.
41. A. Madisch, S. Miehlke, O. Eichele et al., "Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial, " International Journal of ColorectalDisease, vol. 22, no. 12, pp. 1445-1451, 2007.
42. K. Bishu and R. Agarwal, "Acute injury with intravenous iron and concerns regarding long-Termsafety, " Clinical Journal of the American Society of Nephrology, vol. 1, supplement 1, pp. S19-S23, 2006.
43. J. Himmelfarb, P. Stenvinkel, T. A. Ikizler, and R. M. Hakim, "The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia, " Kidney International, vol. 62, no. 5, pp. 1524-1538, 2002.
44. O. Sommerburg, T. Grune, H. Hampl et al., "Does long-Term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients?" Nephrology Dialysis Transplantation, vol. 13, no. 10, pp. 2583-2587, 1998.
45. L. Triolo, M. Malaguti, F. Ansali et al., "Vitamin E-bonded cellulose membrane, lipoperoxidation, and anemia in hemodialysis patients, " Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, vol. 31, no. 2, pp. 185-191, 2003.
46. T. Sakata, R. Furuya, T. Shimazu, M. Odamaki, S. Ohkawa, and H. Kumagai, "Coenzyme Q10 administration suppresses both oxidative and antioxidative markers in hemodialysis patients, " Blood Purification, vol. 26, no. 4, pp. 371-378, 2008.
47. Z. M. Dimitrijevic, T. P. Cvetkovic, V.M. Djordjevic et al., "How the duration period of erythropoietin treatment influences the oxidative status of hemodialysis patients, " International Journal of Medical Sciences, vol. 9, no. 9, pp. 808-815, 2012.
48. C.-H. Guo, P.-C. Chen, G.-S. W. Hsu, and C.-L. Wang, "Zinc supplementation alters plasma aluminum and selenium status of patients undergoing dialysis: A pilot study, " Nutrients, vol. 5, no. 4, pp. 1456-1470, 2013.
49. G. Haklar, I. Yegenaga, and A. S. Yalçin, "Evaluation of oxidant stress in chronic hemodialysis patients: use of different parameters, " Clinica Chimica Acta, vol. 234, no. 1-2, pp. 109-114, 1995.
50. B. Dolegowska, J. Stepniewska, K. Ciechanowski et al., "Does glucose in dialysis fluid protect erythrocytes in patients with chronic renal failure?" Blood Purification, vol. 25, no. 5-6, pp. 422-429, 2007.
51. K. Mera, M. Anraku, K. Kitamura, K. Nakajou, T. Maruyama, and M. Otagiri, "The structure and function of oxidized albumin in hemodialysis patients: its role in elevated oxidative stress via neutrophil burst, " Biochemical and Biophysical Research Communications, vol. 334, no. 4, pp. 1322-1328, 2005.
52. M. Anraku, K. Kitamura, A. Shinohara et al., "Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients, " Kidney International, vol. 66, no. 2, pp. 841-848, 2004.
53. R. A. Ward, R. Ouseph, and K. R. McLeish, "Effects of high-flux hemodialysis on oxidant stress, " Kidney International, vol. 63, no. 1, pp. 353-359, 2003.
54. E. Fragedaki, M. Nebel, N. Schupp et al., "Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis, " Nephrology Dialysis Transplantation, vol. 20, no. 9, pp. 1936-1943, 2005.
55. J. Stepniewska, B. Dolegowska, K. Ciechanowski, E. Kwiatkowska, B. Millo, and D. Chlubek, "Erythrocyte antioxidant defense system in patients with chronic renal failure according to the hemodialysis conditions, " Archives of Medical Research, vol. 37, no. 3, pp. 353-359, 2006.
56. M. Morena, S. Delbosc, A.-M. Dupuy, B. Canaud, and J.-P. Cristol, "Overproduction of reactive oxygen species in end-stage renal disease patients: A potential component of hemodialysis-Associated inflammation, " Hemodialysis International, vol. 9, no. 1, pp. 37-46, 2005.
57. A. R. Migliaccio, "A niche for every cell, for every function, " Haematologica, vol. 98, no. 11, pp. 1660-1663, 2013.
58. D. Pratico, L. Iuliano, A. Mauriello et al., "Localization of distinct F2-isoprostanes in human atherosclerotic lesions, " The Journal of Clinical Investigation, vol. 100, no. 8, pp. 2028-2034, 1997.
59. J.-L. Cracowski, C. Souvignet, N. Quirin et al., "Urinary F2-isoprostanes formation in kidney transplantation, " Clinical Transplantation, vol. 15, no. 1, pp. 58-62, 2001.
60. L. J. Roberts II and J. D. Morrow, "Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation, " Cellular and Molecular Life Sciences, vol. 59, no. 5, pp. 808-820, 2002.
61. J. D. Morrow, K. E. Hill, R. F. Burk, T. M. Nammour, K. F. Badr, and L. J. Roberts II, "A series of prostaglandin F2-like compounds are produced in vivo in humans by a noncyclooxygenase, free radical-catalyzed mechanism, " Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 23, pp. 9383-9387, 1990.
62. S. A. Dillon, G. M. Lowe, D. Billington, and K. Rahman, "Dietary supplementation with aged garlic extract reduces plasma and urine concentrations of 8-iso-prostaglandin F2 in smoking and nonsmoking men and women, " Journal of Nutrition, vol. 132, no. 2, pp. 168-171, 2002.
63. G. Cao, R. L. Prior, R. G. Cutler, and B. P. Yu, "Effect of dietary restriction on serum antioxidant capacity in rats, " Archives of Gerontology and Geriatrics, vol. 25, no. 3, pp. 245-253, 1997.
64. M. Pakfetrat, L. Malekmakan, and M. Hasheminasab, "Diminished selenium levels in hemodialysis and continuous ambulatory peritoneal dialysis patients, " Biological Trace Element Research, vol. 137, no. 3, pp. 335-339, 2010.
65. N. Avissar, D. B. Ornt, Y. Yagil et al., "Human kidney proximal tubules are the main source of plasma glutathione peroxidase, " The American Journal of Physiology-Cell Physiology, vol. 266, no. 2, part 1, pp. C367-C375, 1994.
66. H. Zumkley, H. P. Bertram, and A. Lison, "Aluminum, zinc and copper concentrations in plasma in chronic renal insufficiency, " Clinical Nephrology, vol. 12, no. 1, pp. 18-21, 1979.
67. V. Schettler, E. Wieland, H. Methe, P. Schuff-Werner, and G. A. Müller, "Oxidative stress during dialysis: effect on free radical scavenging enzyme (FRSE) activities and glutathione (GSH) concentration in granulocytes, " Nephrology Dialysis Transplantation, vol. 13, no. 10, pp. 2588-2593, 1998.
68. M. Romeu, R. Nogues, L. Marcas et al., "Evaluation of oxidative stress biomarkers in patients with chronic renal failure: A case control study, " BMC Research Notes, vol. 3, article 20, 2010.
69. I. Ceballos, P. Chauveau, V. Guerin et al., "Early alterations of plasma free amino acids in chronic renal failure, " Clinica Chimica Acta, vol. 188, no. 2, pp. 101-108, 1990.
70. P. S. Ogunro, F. A. Olujombo, M. O. Ajala, and T. T. Oshodi, "The effect of a membrane dialyzer during hemodialysis on the antioxidant status and lipid peroxidation of patients with end-stage renal disease, " Saudi Journal of Kidney Diseases and Transplantation, vol. 25, no. 6, pp. 1186-1193, 2014.
71. H. Trimarchi, M. R. Mongitore, P. Baglioni et al., "Nacetylcysteine reduces malondialdehyde levels in chronic hemodialysis patients-A pilot study, " Clinical Nephrology, vol. 59, no. 6, pp. 441-446, 2003.
72. R. Ramos and A. Martinez-Castelao, "Lipoperoxidation and hemodialysis, " Metabolism: Clinical and Experimental, vol. 57, no. 10, pp. 1369-1374, 2008.
73. K. S. Smith, C.-L. Lee, J. W. Ridlington, S. W. Leonard, S. Devaraj, and M. G. Traber, "Vitamin E supplementation increases circulating vitamin Emetabolites tenfold in end-stage renal disease patients, " Lipids, vol. 38, no. 8, pp. 813-819, 2003.
74. P. Malindretos, P. A. Sarafidis, I. Rudenco et al., "Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: A comparative study between iron sucrose and iron dextran, " American Journal of Nephrology, vol. 27, no. 6, pp. 572-579, 2007.
75. J. Westhuyzen, D. Saltissi, and V. Stanbury, "Oxidative stress and erythrocyte integrity in end-stage renal failure patients hemodialysed using a vitamin E-modified membrane, " Annals of Clinical and Laboratory Science, vol. 33, no. 1, pp. 3-10, 2003.
76. K.-C. Huang, C.-C. Yang, S.-P. Hsu et al., "Electrolyzed-reduced water reduced hemodialysis-induced erythrocyte impairment in end-stage renal disease patients, " Kidney International, vol. 70, no. 2, pp. 391-398, 2006.
77. C. Fumeron, T. Nguyen-Khoa, C. Saltiel et al., "Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients, " Nephrology Dialysis Transplantation, vol. 20, no. 9, pp. 1874-1879, 2005.
78. K. Washio, M. Inagaki, M. Tsuji et al., "Oral vitamin C supplementation in hemodialysis patients and its effect on the plasma level of oxidized ascorbic acid andCu/Zn superoxide dismutase, an oxidative stress marker, " Nephron Clinical Practice, vol. 109, no. 2, pp. c49-c54, 2008.
79. D.-C. Tarng, T.-Y. Liu, and T.-P. Huang, "Protective effect of vitamin C on 8-hydroxy-2-deoxyguanosine level in peripheral blood lymphocytes of chronic hemodialysis patients, " Kidney International, vol. 66, no. 2, pp. 820-831, 2004.
80. J. Himmelfarb, T. Alp Ikizler, C. Ellis et al., "Provision of antioxidant therapy in hemodialysis (Path): A randomized clinical trial, " Journal of theAmerican Society of Nephrology, vol. 25, no. 3, pp. 623-633, 2014.
81. I. G. Fatouros, I. Douroudos, S. Panagoutsos et al., "Effects of L-carnitine on oxidative stress responses in patients with renal disease, "Medicine and Science in Sports and Exercise, vol. 42, no. 10, pp. 1809-1818, 2010.
82. R. Deicher and W. H. Hörl, "Vitamin C in chronic kidney disease and hemodialysis patients, " Kidney and Blood Pressure Research, vol. 26, no. 2, pp. 100-106, 2003.
83. R. Deicher, F. Ziai, C. Bieglmayer, M. Schillinger, and W. H. Hörl, "Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients, " Journal of the American Society of Nephrology, vol. 16, no. 6, pp. 1811-1818, 2005.
84. J. Kaikkonen, E. Porkkala-Sarataho, J.D. Morrowet al., "Supplementation with vitamin E but not with vitamin C lowers lipid peroxidation in vivo in mildly hypercholesterolemic men, " Free Radical Research, vol. 35, no. 6, pp. 967-978, 2001.
85. H.-Y. Huang, L. J. Appel, K. D. Croft, E. R. Miller III, T. A. Mori, and I. B. Puddey, "Effects of vitamin C and vitamin E on in vivo lipid peroxidation: results of a randomized controlled trial, " American Journal of Clinical Nutrition, vol. 76, no. 3, pp. 549-555, 2002.
86. F. Afaq, P. Abidi, and Q. Rahman, "N-Acetyl l-cysteine attenuates oxidant-mediated toxicity induced by chrysotile fibers, " Toxicology Letters, vol. 117, no. 1-2, pp. 53-60, 2000.
87. O. I. Aruoma, B. Halliwell, B. M. Hoey, and J. Butler, "The antioxidant action of N-Acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid, " Free Radical Biology and Medicine, vol. 6, no. 6, pp. 593-597, 1989.
88. G. Vendemiale, I. Grattagliano, M. L. Caruso et al., "Increased oxidative stress in dimethylnitrosamine-induced liver fibrosis in the rat: effect of N-Acetylcysteine and interferon-, " Toxicology and Applied Pharmacology, vol. 175, no. 2, pp. 130-139, 2001.
89. F. Canestrari, U. Buoncristiani, F. Galli et al., "Redox state, antioxidative activity and lipid peroxidation in erythrocytes and plasma of chronic ambulatory peritoneal dialysis patients, " Clinica Chimica Acta, vol. 234, no. 1-2, pp. 127-136, 1995.
90. B. Gonźalez-Diez, M. Cavia, G. Torres, P. Abaigar, V. Camarero, and P. Muñiz, "The effects of 1-year treatment with a haemodiafiltration with on-line regeneration of ultrafiltrate (HFR) dialysis on biomarkers of oxidative stress in patients with chronic renal failure, " Molecular Biology Reports, vol. 39, no. 1, pp. 629-634, 2012.
91. H. Imani, H. Tabibi, S. Atabak, L. Rahmani, M. Ahmadinejad, and M. Hedayati, "Effects of soy consumption on oxidative stress, blood homocysteine, coagulation factors, and phosphorus in peritoneal dialysis patients, " Journal of Renal Nutrition, vol. 19, no. 5, pp. 389-395, 2009.
92. J. Dawson and M. Walters, "Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?" British Journal of Clinical Pharmacology, vol. 62, no. 6, pp. 633-644, 2006.
93. J.-W. Jung, D.-K. Kim, H.-W. Park et al., "An effective strategy to prevent allopurinol-induced hypersensitivity by HLA typing, " Genetics in Medicine, vol. 17, no. 10, pp. 807-814, 2015.
94. T. Akimoto, Y. Morishita, C. Ito et al., "Febuxostat for hyperuricemia in patients with advanced chronic kidney disease, " Drug Target Insights, vol. 8, pp. 39-43, 2014.
95. M. Jamilian and Z. Asemi, "Theeffect of soy intake on metabolic profiles of women with gestational diabetes mellitus, " Journal of Clinical Endocrinology and Metabolism, vol. 100, no. 12, pp. 4654-4661, 2015.
96. M. Hariri, R. Salehi, A. Feizi, M. Mirlohi, R. Ghiasvand, and N. Habibi, "A randomized, double-blind, placebo-controlled, clinical trial on probiotic soy milk and soy milk: effects on epigenetics and oxidative stress in patients with type II diabetes, " Genes and Nutrition, vol. 10, no. 6, article 52, 2015.
97. K. Rowley, K. ODea, Q. Su, A. J. Jenkins, and J. D. Best, "Low plasma concentrations of diet-derived antioxidants in association with microalbuminuria in Indigenous Australian populations, " Clinical Science, vol. 105, no. 5, pp. 569-575, 2003.
98. J. Himmelfarb, J. Kane, E. McMonagle et al., "Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease, " Kidney International, vol. 64, no. 3, pp. 978-991, 2003.
99. M. J. Bek, S. Wahle, B.Müller et al., "Stra13, a prostaglandin E2-induced gene, regulates the cellular redox state of podocytes, " The FASEB Journal, vol. 17, no. 6, pp. 682-684, 2003.
100. R. Ardaillou, D. Chansel, C. Chatziantoniou, and J.-C. Dussaule, "Mesangial AT1 receptors: expression, signaling, and regulation, " Journal of the American Society of Nephrology, vol. 10, no. 1, pp. S40-S46, 1999.
101. S. Higueruelo and R. Romero, "Angiotensin II requires PDGFBB to induce DNA synthesis in rat mesangial cells cultured in an exogenous insulin-free medium, " Nephrology Dialysis Transplantation, vol. 12, no. 4, pp. 694-700, 1997.
102. G. Ding, A. Zhang, S. Huang et al., "ANG II induces c-Jun NH2-Terminal kinase activation and proliferation of human mesangial cells via redox-sensitive transactivation of the EGFR, " The American Journal of Physiology-Renal Physiology, vol. 293, no. 6, pp. F1889-F1897, 2007.
103. S. K. Mallipattu and J. C. He, "The beneficial role of retinoids in glomerular disease, " Frontiers in Medicine, vol. 2, article 16, 2015.